Population Pharmacokinetics and Exposure-Response Relationships of Belimumab Following Subcutaneous Administration in Subjects with Systemic Lupus Erythematosus

被引:0
|
作者
Struemper, Herbert [1 ]
Thapar, Mita [2 ]
Gordon, David [3 ]
Roth, David [3 ]
机构
[1] PAREXEL, Quantitat Clin Dev, Durham, NC USA
[2] ICON, Marlow, Bucks, England
[3] GlaxoSmithKline, Collegeville, PA USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
T-17
引用
收藏
页码:S56 / S56
页数:1
相关论文
共 50 条
  • [41] Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status Epilepticus
    Ku, Lawrence C.
    Hornik, Christoph P.
    Beechinor, Ryan J.
    Chamberlain, James M.
    Guptill, Jeffrey T.
    Harper, Barrie
    Capparelli, Edmund, V
    Martz, Karen
    Anand, Ravinder
    Cohen-Wolkowiez, Michael
    Gonzalez, Daniel
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018, 7 (11): : 718 - 727
  • [42] Population model-based analysis of the memory B-cell response following belimumab therapy in the treatment of systemic lupus erythematosus
    Dimelow, Richard
    Gillespie, William R.
    van Maurik, Andre
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (04): : 462 - 473
  • [43] Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction
    Ahmed, Hamdy M. A.
    Abohamad, Samar
    Elfishawi, Mohanad
    Hegazy, Mohamed Tharwat
    Vijaykumar, Kadambari
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 2475 - 2479
  • [44] Belimumab in systemic lupus erythematosus after inadequate response to a cocktail of active therapies
    Athanassiou, P.
    Tzanavari, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : S36 - S36
  • [45] Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
    van Vollenhoven, Ronald F.
    Petri, Michelle A.
    Cervera, Ricard
    Roth, David A.
    Ji, Beulah N.
    Kleoudis, Christi S.
    Zhong, Z. John
    Freimuth, William
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (08) : 1343 - 1349
  • [46] Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset Seizures
    Schoemaker, Rik
    Wade, Janet R.
    Stockis, Armel
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1591 - 1602
  • [47] Population Pharmacokinetics and Exposure-Response of Subcutaneous Atezolizumab in Patients With Non-Small Cell Lung Cancer
    Chan, Phyllis
    Liu, Stephanie N.
    Gosselin, Nathalie
    Sauve, Zacharie
    Marchand, Mathilde
    Lin, Alyse
    Herraez-Baranda, Luis
    Zanghi, James
    Shearer-Kang, Esther
    Liu, Xiaoyan
    Wu, Benjamin
    Chanu, Pascal
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025,
  • [48] Population pharmacokinetics of enfuvirtide in pediatric patients with human immunodeficiency virus: Searching for exposure-response relationships
    Soy, D
    Aweeka, FT
    Church, JA
    Cunningham, CK
    Palumbo, P
    Kosel, BW
    Sheiner, LB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (06) : 569 - 580
  • [49] Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer
    Monk, Bradley J.
    Romero, Ignacio
    Graybill, Whitney
    Churruca, Cristina
    O'Malley, David M.
    Knudsen, Anja or
    Yap, Oi Wah Stephanie
    Baurain, Jean-Francois
    Rose, Peter G.
    Denys, Hannelore
    Ghamande, Sharad
    Pisano, Carmela
    Fabbro, Michel
    Braicu, Elena Ioana
    Calvert, Paula M.
    Amit, Amnon
    Prendergast, Emily
    Taylor, Adekemi
    Kheibarshekan, Leila
    Zhang, Zhi-Yi
    Zajic, Stefan
    Jewell, Roxanne C.
    Gupta, Divya
    Gonzalez-Martin, Antonio
    CLINICAL THERAPEUTICS, 2024, 46 (08) : 612 - 621
  • [50] Population Pharmacokinetics and Exposure-Response Relationships of Baloxavir Marboxil in Influenza Patients at High Risk of Complications
    Koshimichi, Hiroki
    Retout, Sylvie
    Cosson, Valerie
    Duval, Vincent
    De Buck, Stefan
    Tsuda, Yoshiyuki
    Ishibashi, Toru
    Wajima, Toshihiro
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)